Experimentally induced various inflammatory models and seizure: Understanding the role of cytokine in rat

European Neuropsychopharmacology

Volumn 18, Issue 10, 2008, Pages 760-767

  Rao, R S ^a   Medhi, B ^a   Saikia, U N ^a   Arora, S K ^a   Toor, Jaideep S ^a   Khanduja, K L ^a   Pandhi, P ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Pentylenetetrazole; Seizure; Thalidomide

Indexed keywords

CYTOKINE; ETORICOXIB; PENTETRAZOLE; THALIDOMIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTICONVULSANT ACTIVITY; ARTHRITIS; ARTICLE; COLITIS; CONTROLLED STUDY; DNA FRAGMENTATION; EPILEPTOGENESIS; GRANULOMA; INFLAMMATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SEIZURE;

ACETIC ACID; ANALYSIS OF VARIANCE; ANIMALS; ARTHRITIS; COLITIS; CYCLOOXYGENASE INHIBITORS; CYTOKINES; DISEASE MODELS, ANIMAL; DNA FRAGMENTATION; FREUND'S ADJUVANT; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATION; MALE; PYRIDINES; RATS; RATS, WISTAR; SEIZURES; SULFONES; THALIDOMIDE;

EID: 49649119353     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2008.06.008     Document Type: Article

References (27)

1. Allen B.N. Thalidomide: regains respectability as new benefits are discovered. Pharmaceutical. J. 267 (2001) 124-127
2. Bessis A., Bernard D., and Triller A. Tumor necrosis factor-alpha and neuronal development. Neuroscientist 11 4 (2005) 277-281
3. Burke A., Smyth E., and Fitzgerald G.A. Pharmacotherapy of gout; analgesic-antipyretic agents. In: Brunton L.L., Lazo J.S., and Parker K.L. (Eds). Goodman & Gilman's The Pharmacological Basis of Therapeutics. 11th eds (2006), McGraw-Hill medical publishing division, New York 705
4. Bush I.E., and Alexander R.W. An improved method for the assay of anti-inflammatory substances in rats. Acta. Endocr. 35 (1960) 268-276
5. Dringen R. Oxidative and antioxidative potential of brain microglial cells. Antioxid. Redox. Signal. 9-10 (2005) 1223-1233
6. Gallowitsch-Puerta M., and Pavlov V.A. Neuro-immune interactions via the cholinergic anti-inflammatory pathway. Life. Sci. 80 24-25 (2007) 2325-2329
7. Giorgi O., Orlandi M., Lecca D., and Corda M. MK-801 prevents chemical kindling induced by pentylenetetrazol in rats. Eur. J. Pharmacol. 193 (1991) 363-365
8. Huber J.D., Witt K.A., Hom S., Egleton R.D., Mark K.S., and Davis T.P. Inflammatory pain alters blood-brain barrier permeability and tight junctional protein expression. Am. J. Physiol. Heart. Circ. Physiol. 280 3 (2001) H1241-H1248
9. Hulkkonen J., Koskikallio E., Rainesalo S., Keränen T., Hurme M., and Peltola J. The balance of inhibitory and excitatory cytokines is differently regulated in vivo and in vitro among therapy resistant epilepsy patients. Epilepsy. Res. 59 2-3 (2004) 199-205
10. Imamura S., Matsukawa A., Ohkawara S., Kagayama M., and Yoshinaga M. Involvement of tumor necrosis factor-alpha, interleukin-1 beta, interleukin-8, and interleukin-1 receptor antagonist in acute lung injury caused by local Shwartzman reaction. Pathol. Int. 47 1 (1997) 16-24
11. Kidd B.L., and Urban L.A. Mechanism of inflammatory pain. Br. J. Anaesth. 87 1 (2001) 3-11
12. Klausner J.D., Freedman V.H., and Kaplan G. Thalidomide as an anti-TNF-alpha inhibitor: implications for clinical use. Clin. Immunol. Immunopathol. 81 3 (1996) 219-223
13. Lehmann C., Egerer K., Georgiew A., Weber M., Grune T., and Kox W.J. Inhibition of tumor necrosis factor-alpha release in rat experimental endotoxemia by treatment with the 21-aminosteroid U-74389G. Crit. Care. Med. 27 (1999) 1164-1167
14. Levine A., Kenet G., Bruck R., Avni Y., Avinoach I., Aeed H., et al. Effect of heparin on tissue binding activity of fibroblast growth factor and heparin binding epidermal growth factor in experimental colitis in rats. Pediatric. Res. 51 (2002) 635-640
15. Lowenstein D.H. Seizures and epilepsy. In: Braunwald E., Fauci A.S., Kasper D.L., Hauser S.L., Longo D.L., and Jameson J.L. (Eds). Harrison's Principles of Internal Medicine. 15th ed (2001), McGraw-Hill medical publishing division, New York 2354-2368
16. MacPherson B.R., and Pfeiffer C.J. Experimental production of diffuse colitis. Digestion 17 (1978) 136-150
17. Marchi N., Angelov L., Masaryk T., Fazio V., Granata T., Hernanedez N., Hallene K., Diglaw T., Franic L., Najm I., and Janigro D. Seizure-promoting effect of blood-brain barrier disruption. Epilepsia 48 4 (2007) 732-742
18. Minagar A., and Alexander J.S. Blood-brain barrier disruption in multiple sclerosis. Mult. Scler. 9 6 (2003) 540-549
19. Palencia G., Calderon A., and Sotelo J. Thalidomide inhibits pentylenetetrazole-induced seizures. J. Neurol. Sci. 258 1-2 (2007) 128-131
20. Pearson C.M., and Wood F.D. Studies on polyarthritis and other lesions induced in rats by injection of mycobacterium adjuvant. I. General clinic and pathological characteristics and some modifying factors. Arthr. Rheum. 2 (1959) 440-459
21. Porter R.J. Therapy of epilepsy. Curr. Opin. Neurol. Neurosurg. 1 (1988) 206-211
22. Riazi K., Honar H., Homayoun H., Demehri S., Bahadori M., and Dehpour A.R. Intestinal inflammation alters the susceptibility to pentylenetetrazole-induced seizure in mice. J. Gastroenterol. Hepatol. 19 3 (2004) 270-277
23. Sambrook J., and Russell D.W. Gel electrophoresis of DNA and pulsed-field agarose gel electrophoresis. In: Sambrook J., and Russell D.W. (Eds). Molecular cloning - a laboratory manual. 3 eds vol I (2001), Cold Spring Harbor laboratory press, New York 5.4-5.13
24. INK4a senescence gene as a new therapeutic strategy for the treatment of rheumatoid arthritis. Nat. Med. 5 (1999) 760-767
25. Vezzani A. Inflammation and epilepsy. Epilepsy. Curr. 5 1 (2005) 1-6
26. Virta M., Hurme M., and Helminen M. Incresed plasma levels of pro and anti-inflammatory cytokines in patients with febrile seizures. Epilepsia 43 8 (2002) 920-923
27. Vogel, H.G., Goethe, J.W., Drug discovery and evaluation pharmacological assay. 2nd eds. Germany: Springer,2002. p. 422,767,802,896.